Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Nystatin 100,000units/ml oral suspension |
BNF code | 0502030B0AAABAB |
Virtual Therapeutic Moiety | Nystatin |
Date identifier became valid | 12 May 2023 |
Previous product identifier | 324689003 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Date of name applicability | 14 Feb 2003 |
Previous name | Nystatin 100,000 units/ml oral suspension |
Basis of previous name | rINN - Recommended International Non-proprietary |
Reason for name change | Other |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Continuous |
Virtual Product Ingredient | |
---|---|
Ingredient | Nystatin |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 100000.000 |
Strength value numerator unit | unit |
Strength value denominator | 1.000 |
Strength value denominator unit | ml |
Ontology Drug Form & Route | |
Form & Route | suspension.oral |
Dose Form | |
Formulation | Oral suspension |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Nystan 100,000units/ml oral suspension (ready mixed) (Vygoris Ltd) | |
Nystatin 100,000units/ml oral suspension (Sigma Pharmaceuticals Plc) | |
Virtual Medicinal Product Packs | |
Nystatin 100,000units/ml oral suspension 30 ml |
dm+d data retrieved from TRUD: release NHSBSA_2.0.0_20250203000001, imported on 4th February 2025 at 03:53:58.